These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7568032)

  • 1. Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.
    Pommier Y; Kohlhagen G; Kohn KW; Leteurtre F; Wani MC; Wall ME
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8861-5. PubMed ID: 7568032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 7-alkyl methylenedioxy-camptothecin derivatives exhibit increased cytotoxicity and induce persistent cleavable complexes both with purified mammalian topoisomerase I and in human colon carcinoma SW620 cells.
    Valenti M; Nieves-Neira W; Kohlhagen G; Kohn KW; Wall ME; Wani MC; Pommier Y
    Mol Pharmacol; 1997 Jul; 52(1):82-7. PubMed ID: 9224816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of topoisomerase I cleavage complexes by the vinyl chloride adduct 1,N6-ethenoadenine.
    Pourquier P; Bjornsti MA; Pommier Y
    J Biol Chem; 1998 Oct; 273(42):27245-9. PubMed ID: 9765247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives.
    Tanizawa A; Kohn KW; Kohlhagen G; Leteurtre F; Pommier Y
    Biochemistry; 1995 May; 34(21):7200-6. PubMed ID: 7766631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
    Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
    Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
    Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
    J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation in kinetics of lactone ring hydrolysis of camptothecins upon interaction with topoisomerase I cleavage sites on DNA.
    Chourpa I; Riou JF; Millot JM; Pommier Y; Manfait M
    Biochemistry; 1998 May; 37(20):7284-91. PubMed ID: 9585542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.
    Laco GS; Collins JR; Luke BT; Kroth H; Sayer JM; Jerina DM; Pommier Y
    Biochemistry; 2002 Feb; 41(5):1428-35. PubMed ID: 11814334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.
    Pondarré C; Strumberg D; Fujimori A; Torres-León R; Pommier Y
    Nucleic Acids Res; 1997 Oct; 25(20):4111-6. PubMed ID: 9321666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight of DNA topoisomerases I from camptothecin-producing plants revealed by molecular dynamics simulations.
    Sirikantaramas S; Meeprasert A; Rungrotmongkol T; Fuji H; Hoshino T; Sudo H; Yamazaki M; Saito K
    Phytochemistry; 2015 May; 113():50-6. PubMed ID: 25733498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors.
    Pommier Y; Jenkins J; Kohlhagen G; Leteurtre F
    Mutat Res; 1995 Sep; 337(2):135-45. PubMed ID: 7565862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
    Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
    BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topoisomerase I changes the mode of interaction between camptothecin drugs and DNA as probed by UV-resonance Raman spectroscopy.
    Feofanov AV; Baranov AV; Fleury F; Riou JF; Nabiev IR; Manfait M
    FEBS Lett; 1996 Nov; 396(2-3):289-92. PubMed ID: 8915005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10,11-Methylenedioxycamptothecin, a topoisomerase I inhibitor of increased potency: DNA damage and correlation to cytotoxicity in human colon carcinoma (HT-29) cells.
    O'Connor PM; Kerrigan D; Bertrand R; Kohn KW; Pommier Y
    Cancer Commun; 1990; 2(12):395-400. PubMed ID: 2176090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian DNA topoisomerase I activity and poisoning by camptothecin are inhibited by simian virus 40 large T antigen.
    Pommier Y; Kohlhagen G; Wu C; Simmons DT
    Biochemistry; 1998 Mar; 37(11):3818-23. PubMed ID: 9521701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two models for human topoisomerase I interaction with dsDNA and camptothecin derivatives.
    Laco GS
    PLoS One; 2011; 6(8):e24314. PubMed ID: 21912628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trapping of mammalian topoisomerase I and recombinations induced by damaged DNA containing nicks or gaps. Importance of DNA end phosphorylation and camptothecin effects.
    Pourquier P; Pilon AA; Kohlhagen G; Mazumder A; Sharma A; Pommier Y
    J Biol Chem; 1997 Oct; 272(42):26441-7. PubMed ID: 9334220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting topoisomerase I cleavage to specific sequences of DNA by triple helix-forming oligonucleotide conjugates. A comparison between a rebeccamycin derivative and camptothecin.
    Arimondo PB; Bailly C; Boutorine A; Sun JS; Garestier T; Hélène C
    C R Acad Sci III; 1999 Sep; 322(9):785-90. PubMed ID: 10547719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
    Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
    J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence selectivity of the cleavage sites induced by topoisomerase I inhibitors: a molecular dynamics study.
    Siu FM; Pommier Y
    Nucleic Acids Res; 2013 Dec; 41(22):10010-9. PubMed ID: 24021629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.